Literature DB >> 22595446

Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial.

Apichat Sangchan1, Worrarat Kongkasame, Ake Pugkhem, Kriangsak Jenwitheesuk, Pisaln Mairiang.   

Abstract

BACKGROUND: Endoscopic biliary stent drainage is effective in the palliative treatment of patients with hilar cholangiocarcinoma (HCA). However, no randomized controlled trial comparing the efficacy of the self-expandable metal stent (SEMS) and the plastic stent (PS) in patients with unresectable complex HCA is available.
OBJECTIVE: To compare the successful drainage rates of endoscopic SEMSs and PSs.
DESIGN: A single-center, open-label randomized controlled trial.
SETTING: University hospital in KhonKaen, Thailand. PATIENTS: One hundred eight patients with unresectable complex, Bismuth type II-IV HCA.
INTERVENTIONS: Endoscopic retrograde cholangiography with unilateral SEMS or PS insertion. MAIN OUTCOME MEASUREMENTS: Successful drainage rate. LIMITATIONS: Diagnosis of HCA was made by clinical presentations, imaging studies, and clinical outcome during follow-up.
RESULTS: One hundred eight patients were randomly allocated to the SEMS and PS groups. Intention-to-treat analysis revealed that the successful drainage rate in the SEMS group was higher than in the PS group (70.4% vs 46.3%, P = .011). The median survival times were 126 and 49 days, respectively, in the SEMS and PS groups. The overall survival rates of the patients in both groups were statistically different by log-rank test (P = .002).
CONCLUSIONS: Endoscopic biliary drainage with the SEMS provides better adequacy of drainage and longer survival compared with the PS in patients with unresectable complex HCA.
Copyright © 2012 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22595446     DOI: 10.1016/j.gie.2012.02.048

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  46 in total

Review 1.  Current status of endoscopic biliary drainage for unresectable malignant hilar biliary strictures.

Authors:  Hironari Kato; Koichiro Tsutsumi; Hirofumi Kawamoto; Hiroyuki Okada
Journal:  World J Gastrointest Endosc       Date:  2015-08-25

2.  Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinoma.

Authors:  S O'Brien; N Bhutiani; M E Egger; A N Brown; K H Weaver; D Kline; L R Kelly; C R Scoggins; R C G Martin; G C Vitale
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

3.  Biliary drainage strategy of unresectable malignant hilar strictures by computed tomography volumetry.

Authors:  Ei Takahashi; Mitsuharu Fukasawa; Tadashi Sato; Shinichi Takano; Makoto Kadokura; Hiroko Shindo; Yudai Yokota; Nobuyuki Enomoto
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

Review 4.  Endoscopic management of hilar biliary strictures.

Authors:  Rajiv Ranjan Singh; Virendra Singh
Journal:  World J Gastrointest Endosc       Date:  2015-07-10

5.  Compliance with evidence-based multidisciplinary guidelines on perihilar cholangiocarcinoma.

Authors:  Robert Js Coelen; Joost Huiskens; Pim B Olthof; Eva Roos; Jimme K Wiggers; Annuska Schoorlemmer; Otto M van Delden; Heinz-Josef Klümpen; Erik Aj Rauws; Thomas M van Gulik
Journal:  United European Gastroenterol J       Date:  2016-09-30       Impact factor: 4.623

6.  Impact of infected stent removal on recurrent cholangitis with time-to-event analysis.

Authors:  Pichamol Jirapinyo; Mohd Amer AlSamman; Christopher C Thompson
Journal:  Surg Endosc       Date:  2019-03-29       Impact factor: 4.584

7.  Biliary Decompression in Perihilar Cholangiocarcinoma Improves Survival: A Single-Center Retrospective Analysis.

Authors:  Lisa S Cassani; Jay Chouhan; Christopher Chan; Gandhi Lanke; Hsiang-Chun Chen; Xuemei Wang; Brian Weston; William A Ross; Gottumukkala S Raju; Jeffrey H Lee
Journal:  Dig Dis Sci       Date:  2018-09-20       Impact factor: 3.199

Review 8.  Endoscopic treatment options for cholangiocarcinoma.

Authors:  Linda Ann Hou; Jacques Van Dam
Journal:  Hepat Oncol       Date:  2014-03-20

Review 9.  [Diagnostics and treatment of cholangiocellular carcinoma].

Authors:  L Zender; N P Malek
Journal:  Internist (Berl)       Date:  2016-12       Impact factor: 0.743

Review 10.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.